Markets are Closed
Company Logo
TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares

Open

Previous Open

High

9.87

Previous High

Low

9.63

Previous Low

Close

9.86

Previous Close

Volume

8,722,406

Previous Volume

Company Profile

Description

Teva Pharmaceutical Industries Ltd is a pharmaceutical company which develops, produces and markets generic and specialty medicines which include chemical and therapeutic medicines in a variety of dosage forms and central nervous system medicines.

Exchange

New York Stock Exchange

List Date

March 26, 1990

CEO

Kare Schultz

Employees

51,800

Financials

Revenue

16.88B

Earnings

-455.00M
24B
14B
4B
-5B
-15B
2015
2016
2017
2018

Splits

July 01, 20040.50%
December 06, 20020.50%
February 23, 20000.50%

Dividends

November 27, 2017$0.07
September 14, 2017$0.07
June 22, 2017$0.29
March 20, 2017$0.29
December 20, 2016$0.29
September 08, 2016$0.29
June 07, 2016$0.29
March 14, 2016$0.29
December 03, 2015$0.29
September 03, 2015$0.29
June 04, 2015$0.29
March 03, 2015$0.29
December 02, 2014$0.27
September 04, 2014$0.29
June 02, 2014$0.30
March 10, 2014$0.29
December 03, 2013$0.28
September 03, 2013$0.27

Related News

News post image: Teva Pharmaceutical Finance Netherlands IV BV -- Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Finance Netherlands IV BV -- Moody's announces completion of a periodic review of ratings of Teva Pharmaceutical Industries Ltd
Jan 14, 2020 @ 17:59
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Teva Pharmaceutical Industries Ltd and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers. Since 1 January 2019, Moody's practice has been to issue a press release following each periodic review to announce its completion....
finance yahoo
News post image: Is Mylan (MYL) Doomed to Witness a Terrible 2020 Too?
Is Mylan (MYL) Doomed to Witness a Terrible 2020 Too?
Dec 27, 2019 @ 14:24
As Mylan (MYL) remained plagued with challenges in 2019, we take an insight into whether or not, the next year holds any promise for the company....
finance yahoo
News post image: Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy
Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy
Dec 24, 2019 @ 15:12
Allergan (AGN) gets FDA nod for Ubrelvy for the acute treatment of migraine with or without aura in adults....
finance yahoo
News post image: Teva Pharmaceutical Industries Ltd. (TEVA) Outpaces Stock Market Gains: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) Outpaces Stock Market Gains: What You Should Know
Dec 19, 2019 @ 22:50
Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $9.97, moving +1.73% from the previous trading session....
finance yahoo
News post image: IWH UK Midco Limited -- Moody's affirms IWH's (aka Theramex) B2 ratings; changes outlook to negative
IWH UK Midco Limited -- Moody's affirms IWH's (aka Theramex) B2 ratings; changes outlook to negative
Nov 27, 2019 @ 11:56
Moody's Investors Service ("Moody's") has affirmed all the ratings of London-based women's health company IWH UK Finco Limited ('Theramex'), comprising the B2 corporate family rating (CFR), the B2-PD probability of default rating (PDR) and B2 instrument ratings on the existing senior secured facilities borrowed by IWH UK Midco Limited. "Today's outlook change to negative primarily reflects Theramex's significant free cash flow consumption since the closing of the LBO in January 2018, which was well in excess of our expectations because of higher than anticipated carve-out costs" says Frederic Duranson, a Moody's Assistant Vice President and lead analyst for Theramex. "Although we expect that Theramex will generate free cash flow in 2020, its liquidity position is substantially weaker than we had anticipated at the time of the LBO by CVC and debt funding to finance the acquisition of drug licenses will slow down its gross deleveraging" Mr Duranson adds....
finance yahoo
News post image: Teva Pharmaceutical Industries Ltd. (TEVA) Dips More Than Broader Markets: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) Dips More Than Broader Markets: What You Should Know
Jul 17, 2019 @ 21:50
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.11 in the latest trading session, marking a -1.1% move from the prior day....
finance yahoo
News post image: Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Jun 20, 2019 @ 21:45
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.12 in the latest trading session, marking a -0.73% move from the prior day....
finance yahoo
News post image: Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Jun 13, 2019 @ 21:45
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $8.62 in the latest trading session, marking a -1.03% move from the prior day....
finance yahoo
News post image: Hedge Funds Are Dumping Teva Pharmaceutical Industries Limited (TEVA)
Hedge Funds Are Dumping Teva Pharmaceutical Industries Limited (TEVA)
Jun 10, 2019 @ 14:27
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter. One of these stocks was Teva Pharmaceutical Industries Limited (NYSE:TEVA). Teva Pharmaceutical...
finance yahoo
News post image: Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Sinks As Market Gains: What You Should Know
Jun 07, 2019 @ 21:45
Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.26 in the latest trading session, marking a -1.59% move from the prior day....
finance yahoo